ctrl K

Watchlist Price Alert

Repare Therapeutics Inc. (RPTX)

NASDAQ: RPTX · Real-Time Price · USD

1.43

-0.02 (-1.38%)

At close: Jun 17, 2025, 12:43 PM

Repare Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	53.48M	51.13M	131.83M	7.6M	135K	n/a	n/a	n/a
Cost of Revenue	1.92M	131.2M	4.18M	3.34M	1.79M	968K	407K	102K
Gross Profit	51.56M	-80.07M	127.65M	4.26M	-1.65M	-968K	-407K	-102K
Operating Income	-93.52M	-116.22M	-19.8M	-108.66M	-54.3M	-26.38M	-12.82M	-6.17M
Interest Income	10.39M	13.33M	5.63M	259K	240K	n/a	n/a	n/a
Pretax Income	-83.25M	-103.18M	-13.9M	-108.59M	-54.74M	-27.02M	-14.25M	-7.8M
Net Income	-84.69M	-93.8M	-29.05M	-106.91M	-53.42M	-27.22M	-14.28M	-7.8M
Selling & General & Admin	29.68M	33.76M	32.56M	26.21M	14.35M	5.38M	2.91M	1.77M
Research & Development	115.94M	133.59M	119.07M	90.05M	40.09M	21M	9.91M	4.4M
Other Expenses	1.38M	n/a	-43K	-41K	-16K	-1.36M	-1.14M	-1.47M
Operating Expenses	147M	167.36M	151.63M	116.26M	54.44M	26.38M	12.82M	6.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	147M	167.36M	151.63M	116.26M	54.44M	26.38M	12.82M	6.17M
Income Tax Expense	1.44M	-9.38M	15.15M	-1.68M	-1.32M	195K	35K	147K
Shares Outstanding (Basic)	42.41M	42.09M	41.92M	37.82M	36.9M	36.67M	15.79M	15.79M
Shares Outstanding (Diluted)	42.41M	42.09M	41.92M	37.82M	36.9M	36.67M	15.79M	15.79M
EPS (Basic)	-2	-2.23	-0.69	-2.83	-1.45	-0.74	-0.9	-0.49
EPS (Diluted)	-2	-2.23	-0.69	-2.83	-1.45	-0.74	-0.9	-0.49
EBITDA	-93.52M	-114.27M	-17.82M	-107.19M	-53.41M	-25.49M	-13.51M	-7.53M
EBIT	-92.14M	-116.22M	-19.8M	-108.66M	-54.3M	-26.45M	-13.92M	-7.63M
Depreciation & Amortization	1.92M	1.95M	4.18M	3.34M	1.79M	968K	407K	102K